SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jef saunders who wrote (7860)10/16/2001 11:11:40 PM
From: Montana Wildhack  Read Replies (1) of 14101
 
Jef,

I'm not sure that's bad for Pennsaid if they spend
a lot of money raising awareness of non-systemic
delivery and the dangers of using systemic solutions
to local problems.

It sounds as though this would target Celebrex and Vioxx
as being the wrong answers.

It will be interesting to read what this is about since
there's nothing sophisticated enough to travel throughout
the body not using the blood stream. And if its travelling
through the blood stream, release an ingredient locally
without dispersing throughout other parts of the blood
stream. I'm also not aware of anything that can carry
on board a process that can measure variation from a
normal condition or target only a pre-set condition,
although biological machrophages come to mind.

I have read of advances in nanotechnology that can do
precisely this. That is execute an action by actively
searching for a pre-set condition trigger.

This could be really interesting.

Wolf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News